EDF Ventures is a leading venture capital firm investing in early-stage healthcare companies. Our partners bring deep domain knowledge, extensive networks and a distinguished track record to every endeavor. Testimonials Featured Portfolio Company News Direct Flow Medical Receives IDE Approval for U.S. Salus Trial of Transcatheter Aortic Heart Valve System Lycera Appoints Bruce Goldsmith, Ph.D., as Chief Business Officer Lycera Enters Into a Collaboration Agreement with Merck Direct Flow Medical Receives CE Mark for Transcatheter Aortic Heart Valve System that Virtually Eliminates Aortic Regurgitation Direct Flow Medical's Patient Results from their CE Mark Trial in Europe announced at the 2012 TCT Conference Cerenis Therapeutics selected as a 2012 Red Herring Top 100 Europe
Please do not submit any information or other materials that you consider to be confidential or proprietary. Because of the large number of business plans and related materials that EDF Ventures reviews, and the similarity of many such plans and materials, EDF Ventures cannot accept responsibility for protecting against misuse or disclosure of any confidential or proprietary information or other materials in the absence of EDF Ventures' express written agreement to do so. Terms  |  Privacy